TissueTech

The Pioneer of Ophthalmology
Where Healing Comes Naturally

  • Patented CryoTek process
  • The ONLY FDA cleared therapeutic amniotic membrane device
  • FDA and AATB Approval
  • Over 300,000 user experiences in worldwide

TissueTech’s initial research and development efforts were focused on the development of its cornerstone cryopreservation technology – CryoTek. The CryoTek process is a proprietary tissue-processing method that preserves the innate biological and structural integrity of the natural placental. CryoTek-processed tissues are also the only available placental allografts that have been shown to be equivalent to fresh placental tissue and superior to other available placental allografts that are provided in a dehydrated state.